The AHA, Association of American Medical Colleges, America’s Essential Hospitals, 340B Health and three hospital systems today opposed the Department of Health and Human Services motion to stay in the groups’ lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.  

 

“Plaintiffs have been forced to wait more than eight years for the benefit of regulations required by Congress to protect them from overcharging by drug manufacturers,” the hospital groups’ memo said. “Defendants’ submission to OMB [Office of Management and Budget] of a proposed rule – without any assurance that the final 340B rule will actually be implemented by Jan. 1, 2019 – is not a basis for a stay, and defendants’ other arguments for delay are meritless.”

 

The memo also urges the court to order HHS to respond to the hospital groups’ “summary judgment motion within 7-10 days, to permit an expeditious resolution of plaintiffs’ claims.”

 

The AHA and other groups last month asked a federal court to order HHS to make effective within 30 days a final rule requiring drug companies to disclose the ceiling price for 340B outpatient drugs. To ensure accuracy and compliance with the 340B drug savings program, the rule also describes how ceiling prices must be calculated and would allow the federal government to levy civil monetary penalties against drug companies that intentionally overcharge 340B providers.

Related News Articles

Insights and Analysis
As the 2019 chair of the AHA’s Section for Small or Rural Hospitals, I can attest that AHA is stepping up in a big way to grapple with the issues that affect…
Headline
Congress last night approved legislation providing discretionary funding for certain federal programs for fiscal year 2019, preventing a shutdown of those…
Blog
Earlier this month AHA released a blog post that pointed out numerous flaws in a recent Health Affairs study on hospital and physician prices between 2007 and…
Headline
The AHA and Federation of American Hospitals today urged the U.S. Supreme Court to review a federal appeals court decision that allows False Claims Act…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on legislation to roll back changes to the Affordable Care Act by the Trump…
Headline
The AHA yesterday urged Sens. Bill Cassidy, R-La., and Dick Durbin, D-Ill., not to re-introduce legislation that would establish rehabilitation innovation…